A neurological disease paradigm shift

Scientists argue that Parkinson’s disease complexity demands a new way of classifying the disease for research purposes, one based not on clinical diagnosis but biology. The authors have called their biological model ‘SynNeurGe’.

A new drug candidate can shrink kidney cysts

A compound originally developed as a cancer treatment may hold promise for treating polycystic kidney disease (ADPKD), which affects more than half a million Americans and can lead to kidney enlargement and loss of function.